EPIRUS Biopharmaceuticals IncOver The Counter Market:EPRSQ
No Matches were found for
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
No documents available
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
EPIRUS Biopharmaceuticals Inc | 30.0 | 0.0x | --- |
Corix Bioscience Inc | 20.0 | 0.0x | --- |
Applied Biosciences Corp | 4.4K | 0.0x | --- |
AVAX Technologies Inc | 14.3K | 0.0x | --- |
Peak Bio Inc | 192.4K | 0.0x | --- |
Viropro Inc | 1.2K | 0.0x | --- |
Company Information
EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.
Contact Information
- Headquarters
- 699 Boylston Street 8th FloorBOSTON, MA, United States 02116
- Phone
- 617-600-3497
- Fax
- 302-655-5049
Executives
- Senior Vice President, General Counsel, Secretary
- Robert Ticktin
- Chief Business Officer
- Vincent Aurentz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.00 |
|---|---|
Revenue (TTM) | $1.5M |
Shares Outstanding | 26.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.76 |
EPS | $-2.53 |
Book Value | $1.49 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,061.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
